Wound Debridement Market Report

Wound Debridement Market Analysis Report By Product (Gels, Ointments & Creams), By Method, By Wound Type (Diabetic Foot, Pressure Ulcers), By End Use, And Segment Forecasts, 2018 - 2025

  • Published Date: Oct, 2018
  • Base Year for Estimate: 2017
  • Report ID: GVR-2-68038-462-8
  • Format: Electronic (PDF)
  • Historical Data: 2014 - 2016
  • Number of Pages: 120

Report Overview

The global wound debridement market size was valued at USD 4.34 billion in 2017. It is likely to register a CAGR of 6.10% during the forecast period. Growing number of accidents and fire outbreaks are leading to rise in the cases of injuries. This, in turn, is stoking the growth of the market. Besides this, increase in wounds induced by diabetes due to rising incidence of the condition is providing an upthrust to the market.

North America wound debridement market size

In addition, spiraling adoption of debridement products and techniques to heal a wound faster is propelling the market. The presence of micro-organisms and toxins on the wound inhibits healing and may lead to infection. Debridement removes the dead or infected tissues from the wound in order to promote healing. Increasing initiatives by government and private organizations to raise awareness regarding wound care treatment is projected to work in favor of the market.

Rising incidence of ulcers is anticipated to further boost the growth of the market. As per statistics by the American Diabetes Association, in 2014, about 2.0% of the population of the U.S. was affected with diabetic ulcer. Similarly, about 600,000 people are affected by venous ulcer in the country every year. 

Moreover, improving healthcare facilities in several parts of the world and introduction of reimbursement policies are poised to stimulate the growth of the market. Apart from this, advent of advanced wound care products and their increased adoption are positively influencing the growth of the market. Widening base of the geriatric population is also estimated to contribute to the growth of the market.

Product Insights

Based on products, the market has been segmented into gel, ointment & creams, ultrasonic devices, surgical devices, medical gauzes, and other debridement products. Gel accounted for the largest share in 2017 due to its benefits such as no inflammation, less bleeding, and removal of necrotic tissues safely, without causing infection.

Ultrasonic devices have been estimated to be the fastest-growing segment owing to its ability to kill micro-organisms at wound site without damaging blood vessels. The ultrasonic device also differentiates non-viable tissues and viable tissues and removes only non-viable tissues without affecting healthy ones.

Method Insights

The market, on the basis of method, has been segmented into autolysis, enzymatic, mechanical, surgical, and others. Surgical debridement represented the largest share in the market as this procedure is rapid and is applicable to many types of wounds. Mechanical debridement is the most common procedure due to increasing incidence of minor injuries and surging demand for cost-efficient treatment.

On the other hand, autolytic debridement has been expected to be the fastest-growing segment due to its self-healing properties, wherein body’s own moisture and enzymes help in recovery of the wound. However, autolytic debridement is limited to wounds that are not infected or with lesser amount of dead tissues. Autolytic debridement can be enhanced using hydrogels, hydrocolloids, and transparent films.

End-use Insights

By end-use, the wound debridement market is divided into hospitals, home care, and others. Hospital was the most prominent segment in the market in 2017. Increasing surgical procedures and growing incidence of chronic wounds are likely to support the dominance of the segment throughout the forecast period. In addition, the presence of skilled professionals and improving infrastructure in developing economies are also boosting the growth of the segment.

Homecare is anticipated to be the most promising segment during the forecast period. Most of the surgeries involve an extended healing time, which may require frequent changing of dressings. This factor is projected to supplement the growth of the market. Wound debridement in homecare settings has evolved with introduction of single-use NPWT systems. This is primarily due to their lightweight, portability, and canister-free feature.

Wound Type Insights

In terms of wound type, the market has been categorized into pressure ulcers, diabetic foot ulcers, venous leg ulcers, and burn injuries. Diabetic foot ulcers are observed as the fastest growing segment due to increasing prevalence of diabetes. About 15.0% of diabetic foot ulcers result in amputation, therefore, need to heal the wound in its nascent stage is necessary.

Pressure ulcers, on the other hand, held the largest share in the market in 2017 owing to increasing incidence of bedsores. In addition, skin of aged people is highly sensitive and is more prone towards developing bedsores, thereby bolstering the growth of the segment.

Regional Insights

North America was the leading revenue contributor in the global arena in 2017, with a share of approximately 40.0%. The growth of the region can be attributed to the presence of developed medical infrastructure and increasing patient awareness coupled with rising disposable income and soaring need for quality medical products and services.

Global wound debridement market share

Asia Pacific is poised to witness lucrative growth during the forecast period. Booming economies, reforms to improve infrastructure, high unmet needs of huge population, and availability of skilled labor are triggering the growth of the regional market. Europe is also estimated to hold a sizeable share in the market during the same period.

Wound Debridement Market Share Insights

Some of the prominent companies operating in the market are Acelity L.P. Inc.; Smith & Nephew; B. Braun Melsungen AG; Coloplast A/S; ConvaTec Group; Paul Hartmann; Mölnlycke Health Care; Lohmann & Rauscher; Medline Industries; and Integra Lifesciences.

These players, in order to gain a higher market share, are involved in various strategic initiatives such as collaborations, regional expansion, service portfolio expansion, mergers, and acquisitions. For instance, in June 2018, Acelity L.P. Inc. acquired Crawford Healthcare to expand its advanced wound dressing portfolio and thereby, strengthening its position as the global leader in advanced wound care.

Wound Debridement Market Report Scope

Report Attribute


Market size value in 2020

USD 5.15 billion

Revenue forecast in 2025

USD 6.97 billion

Growth Rate

CAGR of 6.10% from 2018 to 2025

Base year for estimation


Historical data

2014 - 2016

Forecast period

2018 - 2025

Quantitative units

Revenue in USD million and CAGR from 2018 to 2025

Report coverage

Revenue forecast, company share, competitive landscape, growth factors and trends

Segments covered

Product, method, wound type, end use, region

Regional scope

North America; Europe; Asia Pacific; Latin America; MEA

Country scope

U.S.; Canada; U.K.; Germany; Japan; China; Brazil; Mexico; South Africa; Saudi Arabia

Key companies profiled

Acelity L.P. Inc.; Smith & Nephew; B. Braun Melsungen AG; Coloplast A/S; ConvaTec Group; Paul Hartmann; Mölnlycke Health Care; Lohmann & Rauscher; Medline Industries; and Integra Lifesciences

Customization scope

Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of industry trends in each of the sub-segments from 2014 to 2025. For the purpose of this study, Grand View Research, Inc. has segmented the global wound debridement market report on the basis of product, method, wound type, end use, and region:

  • Product Outlook (Revenue, USD Million, 2014 - 2025)

    • Gels

    • Ointment & Creams

    • Surgical Devices

    • Medical Gauze & pads

    • Ultrasonic Devices

    • Others

  • Method Outlook (Revenue, USD Million, 2014 - 2025)

    • Autolytic

    • Enzymatic

    • Surgical

    • Mechanical

    • Others

  • Wound Type Outlook (Revenue, USD Million, 2014 - 2025)

    • Pressure ulcer

    • Diabetic foot ulcer

    • Venous leg ulcer

    • Burn wounds

    • Others

  • End-use Outlook (Revenue, USD Million, 2014 - 2025)

    • Hospital

    • Homecare

    • Others

  • Regional Outlook (Revenue, USD Million, 2014 - 2025)

    • North America

      • The U.S.

      • Canada

    • Europe

      • Germany

      • The U.K.

    • Asia Pacific

      • Japan

      • China

    • Latin America

      • Brazil

      • Mexico

    • Middle East and Africa (MEA)

      • South Africa

      • Saudi Arabia

Frequently Asked Questions About This Report

Pricing & Purchase Options

Service Guarantee

  • Insured Buying

    This report has a service guarantee. We stand by our report quality.

  • Confidentiality

    We are in compliance with GDPR & CCPR norms. All interactions are confidential.

  • Custom research service

    Design an exclusive study to serve your research needs.

  • 24/5 Research support

    Get your queries resolved from an industry expert.

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities